Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab + trastuzumab + chemotherapy vs placebo + trastuzumab + chemotherapy in HER2-positive metastatic gastric/GEJ cancer
CTR20140161Phase 3Active
- Sponsor
- Roche
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pertuzumab in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Roche. Started Apr 2014; status: active.
02
Drugs
pertuzumab
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on CTR20140161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140161.